<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503384</url>
  </required_header>
  <id_info>
    <org_study_id>15411950401</org_study_id>
    <nct_id>NCT02503384</nct_id>
  </id_info>
  <brief_title>Clinical and Basic Study for Pediatric Liver Transplantation</brief_title>
  <acronym>CBSPLT</acronym>
  <official_title>Clinical and Basic Study for Pediatric Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: In mainland China, the development of pediatric liver transplantation (LT) has&#xD;
      lagged behind that of adult LT during the past two decades, but it has been progressing&#xD;
      immensely in recent years. Renji hospital(shanghai) is currently the largest pediatric&#xD;
      transplant center in mainland China.&#xD;
&#xD;
      Aim and method: This study is performed for establishment of key techniques for pediatric LT&#xD;
      in mainland China, including the indications and timing for pediatric LT, the criteria for&#xD;
      donor selections, living donor LT planning, prevention and treatment for posttransplant&#xD;
      complications, long-term follow-up management et al.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Outcome measures:&#xD;
&#xD;
        -  Annual caseloads of pediatric liver transplantation&#xD;
&#xD;
        -  Patient survival: 1-, 3- and 5-year patient survival after liver transplantation&#xD;
&#xD;
        -  Graft survival: 1-, 3- and 5-year graft survival after liver transplantation&#xD;
&#xD;
        -  Posttransplant complications, such as biliary complications, vascular complications,&#xD;
           acute rejections, infections et al.&#xD;
&#xD;
        -  Perioperative data, such as duration of operations, postoperative hospital stay et al.&#xD;
&#xD;
        -  Clinical data for living donors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient survival</measure>
    <time_frame>up to 36 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Graft survival</measure>
    <time_frame>up to 36 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Annual caseload for pediatric liver transplantation</measure>
    <time_frame>up to 36 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Biliary Atresia</condition>
  <condition>Metabolic Disorders</condition>
  <condition>Fulminant Liver Failure</condition>
  <condition>Hepatic Tumors</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric liver transplantation cases&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children with end-stage liver diseases&#xD;
&#xD;
          -  Children with metabolic disorders for whom liver transplantation are required&#xD;
&#xD;
          -  Children with fulminant liver failure&#xD;
&#xD;
          -  Children with unresectable hepatic tumors&#xD;
&#xD;
          -  Other miscellaneous conditions which need liver transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Recipient age â‰¥ 18 years&#xD;
&#xD;
          -  Patients with metastatic liver tumors&#xD;
&#xD;
          -  Severe systmatic infections&#xD;
&#xD;
          -  Acquired Immune Deficiency Syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiang Xia, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhifeng Xi, MD</last_name>
    <email>yyzs_0@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University</name>
      <address>
        <city>Shanghai</city>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiang Xia, MD, PhD</last_name>
      <email>xiaqiang@medmail.com.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>July 17, 2015</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2015</study_first_posted>
  <last_update_submitted>July 17, 2015</last_update_submitted>
  <last_update_submitted_qc>July 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Neoplasms</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Biliary Atresia</mesh_term>
    <mesh_term>Liver Failure, Acute</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

